Naproxen and Genotropin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Naproxen (naproxen) and Genotropin (somatropin recombinant). Common drug interactions include aspartate aminotransferase increased among females and pain in extremity among males.

The phase IV clinical study analyzes what interactions people have when they take Naproxen and Genotropin. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Naproxen?

Naproxen has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 72,033 Naproxen users. Check the latest studies of Naproxen.

What is Genotropin?

Genotropin has active ingredients of somatropin recombinant. It is often used in growth hormone deficiency. eHealthMe is studying from 41,924 Genotropin users. Check the latest studies of Genotropin.



On Aug, 10, 2026

29 people who take Naproxen and Genotropin together, and have interactions are studied.

Naproxen and Genotropin drug interactions.

What are the common drug interactions of Naproxen and Genotropin, by gender? *:

female:

  1. Aspartate aminotransferase increased
  2. Fatigue (feeling of tiredness)
  3. Pain in extremity
  4. Atelectasis (partial or complete collapse of the lung)
  5. Histiocytosis haematophagic
  6. Rash erythematous (redness of the skin)
  7. Arthralgia (joint pain)
  8. Alanine aminotransferase increased
  9. Blood pressure decreased
  10. Activities of daily living impaired

male:

  1. Pain in extremity
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Injection site pain
  4. Neck pain
  5. Oesophagitis (inflammation of oesophagus)
  6. Pyrexia (fever)
  7. Road traffic accident
  8. Weight decreased
  9. Abnormal behaviour
  10. Atrial tachycardia (rhythm disturbance that arises in the atria)

What are the common drug interactions of Naproxen and Genotropin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Difficulty in walking
  2. Joint contracture (a permanent shortening of a muscle or joint)

10-19:

  1. Atelectasis (partial or complete collapse of the lung)
  2. Histiocytosis haematophagic
  3. Pain in extremity
  4. Pyrexia (fever)
  5. Rash erythematous (redness of the skin)
  6. Alanine aminotransferase increased
  7. Aspartate aminotransferase increased
  8. Blood pressure decreased
  9. Arthralgia (joint pain)
  10. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)

20-29:

  1. Hypoaesthesia (reduced sense of touch or sensation)
  2. Muscular weakness (muscle weakness)
  3. Pain in extremity

30-39:

  1. Fatigue (feeling of tiredness)
  2. Pain in extremity

40-49:

  1. Fatigue (feeling of tiredness)
  2. Somnolence (a state of near-sleep, a strong desire for sleep)
  3. Spinal column injury (spinal cord bone injury)
  4. Arthralgia (joint pain)
  5. Death
  6. Drug ineffective
  7. Infusion related reaction
  8. Joint swelling
  9. Peripheral swelling
  10. Rib fracture

50-59:

  1. Activities of daily living impaired
  2. Aspartate aminotransferase increased
  3. Blood glucose increased
  4. Blood thyroid stimulating hormone decreased
  5. Glycosylated haemoglobin increased
  6. Hot flush (sudden feelings of heat)
  7. Injection site bruising

60+:

  1. Weight decreased
  2. Oedema peripheral (superficial swelling)
  3. Pain in extremity

What are the existing conditions these people have? *

  1. Hypersensitivity: 3 people, 10.34%
  2. Growth Retardation (delayed growth): 3 people, 10.34%
  3. Hyperhidrosis (abnormally increased sweating): 2 people, 6.90%
  4. Heart Valve Incompetence (heart's valves do not work correctly): 2 people, 6.90%
  5. Headache (pain in head): 2 people, 6.90%
  6. Hangnail (torn piece of skin next to a fingernail): 2 people, 6.90%
  7. Failure To Thrive (inadequate weight gain and physical growth in children): 2 people, 6.90%
  8. Depression: 2 people, 6.90%
  9. Body Height Below Normal: 2 people, 6.90%
  10. Asthma: 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Naproxen and Genotropin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Naproxen and Genotropin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Naproxen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Genotropin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naproxen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Genotropin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on naproxen and somatropin recombinant (the active ingredients of Naproxen and Genotropin, respectively), and Naproxen and Genotropin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: